Outcomes of Adjuvant Chemoradiation After Pancreaticoduodenectomy With Mesenterico-Portal Vein Resection for Adenocarcinoma of the Pancreas

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 1, 2010, Pages 176-180

  Hristov, Boris ^a   Reddy, Sushanth ^a   Lin, Steven H ^a   Cameron, John L ^a   Pawlik, Timothy M ^a   Hruban, Ralph H ^a   Swartz, Michael J ^a   Edil, Barish H ^a   Kemp, Clinton ^a   Wolfgang, Christopher L ^a   Herman, Joseph M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemoradiation; Mesenterico portal reconstruction; Morbidity; Pancreatic cancer; Pancreaticoduodenectomy; Survival; Vein resection

Indexed keywords

ADENOCARCINOMA OF THE PANCREAS; BLOOD LOSS; CHEMORADIATION; CLINICAL OUTCOME; DATA SUPPORT; HOPKINS; INTRA-OPERATIVE; MEDIAN SURVIVAL; OVERALL SURVIVAL; OVERALL SURVIVAL RATES; PANCREATIC ADENOCARCINOMA; PANCREATIC CANCERS; PORTAL VEINS;

CHEMOTHERAPY; FLUORINE CONTAINING POLYMERS; GRAFTING (CHEMICAL); HOSPITALS; PATIENT MONITORING; TELEVISION PICTURE TUBES;

FLUORESCENT SCREENS;

FLUOROURACIL;

ABDOMINAL PAIN; ADULT; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MESENTERIC VEIN; NAUSEA; OPERATION DURATION; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PORTAL VEIN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME; VEIN SURGERY; VOMITING;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; FEMALE; FLUOROURACIL; HUMANS; LENGTH OF STAY; MALE; MESENTERIC VEINS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PORTAL VEIN; RADIOTHERAPY, ADJUVANT; TIME FACTORS;

EID: 72049099310     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.01.047     Document Type: Article

References (18)

1. Schneider G., Siveke J.T., Eckel F., et al. Pancreatic cancer: Basic and clinical aspects. Gastroenterology 128 (2005) 1606-1625
2. Kalser M.H., and Ellenberg S.S. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120 (1985) 899-903
3. Herman J.M., Swartz M.J., Hsu C.C., et al. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: Results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol 26 (2008) 3503-3510
4. Klinkenbijl J.H., Jeekel J., Sahmoud T., et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230 (1999) 776-782
5. Neoptolemos J.P., Stocken D.D., Friess H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350 (2004) 1200-1210
6. Cameron J.L., Riall T.S., Coleman J., et al. One thousand consecutive pancreaticoduodenectomies. Ann Surg 244 (2006) 10-15
7. Greene F.L. American Joint Committee on Cancer, American Cancer Society. AJCC Cancer Staging Manual. 6th ed (2002), Springer-Verlag, New York
8. Tseng J.F., Tamm E.P., Lee J.E., et al. Venous resection in pancreatic cancer surgery. Best Pract Res Clin Gastroenterol 20 (2006) 349-364
9. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: Randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236 (2002) 355-366
10. Katz M.H., Pisters P.W., Evans D.B., et al. Borderline resectable pancreatic cancer: The importance of this emerging stage of disease. J Am Coll Surg 206 (2008) 833-846
11. Tseng J.F., Raut C.P., Lee J.E., et al. Pancreaticoduodenectomy with vascular resection: Margin status and survival duration. J Gastrointest Surg 8 (2004) 935-949
12. Shimada K., Sano T., Sakamoto Y., et al. Clinical implications of combined portal vein resection as a palliative procedure in patients undergoing pancreaticoduodenectomy for pancreatic head carcinoma. Ann Surg Oncol 13 (2006) 1569-1578
13. Adham M., Mirza D.F., Chapuis F., et al. Results of vascular resections during pancreatectomy from two European centres: An analysis of survival and disease-free survival explicative factors. HPB (Oxford) 8 (2006) 465-473
14. Illuminati G., Carboni F., Lorusso R., et al. Results of a pancreatectomy with a limited venous resection for pancreatic cancer. Surg Today 38 (2008) 517-523
15. Yekebas E.F., Bogoevski D., Cataldegirmen G., et al. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg 247 (2008) 300-309
16. Al-Haddad M., Martin J.K., Nguyen J., et al. Vascular resection and reconstruction for pancreatic malignancy: A single center survival study. J Gastrointest Surg 11 (2007) 1168-1174
17. Leach S.D., Lee J.E., Charnsangavej C., et al. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 85 (1998) 611-617
18. Fuhrman G.M., Leach S.D., Staley C.A., et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg 223 (1996) 154-162